Ensuring equitable access to care for veterans
The MultiCare Yakima Memorial Veteran Advocacy Program helps ensure that the community’s nearly 11,000 veterans have equitable access to services and benefits.
The goals of the program are to identify specific needs of the veteran population and help them overcome barriers to accessing care.
PNW PACE Partners provides innovative care for seniors
Older adults are the fastest-growing population segment in the United States, and many in this age group have complex medical and social needs that may not be well met by traditional health care models.
Pacific Northwest (PNW) PACE Partners, part of MultiCare, provides an alternative model of care that aims to support the health, safety and independence of vulnerable seniors while reducing the burden for family caregivers who may struggle to support them.
MultiCare nurses help launch systemwide mobility program
Nurses across MultiCare championed a new program in 2023 that gets patients up and moving more quickly. The #everyBODYmoves program, which originated at The Johns Hopkins Hospital in Baltimore, uses research to improve our reliability in mobilizing patients.
MultiCare Research Institute receives $1.4 million to increase diversity in cancer trials
Clinical trials drive improvements in care and treatment for all kinds of cancers, yet many groups, from communities of color to LGBTQ+ individuals, have historically been underrepresented in oncology research.
In 2023, the Andy Hill Cancer Research Endowment (CARE) Fund awarded two grants totaling more than $1.4 million to the MultiCare Institute for Research & Innovation for projects aimed at increasing participation and diversity in cancer clinical trials.
Healthy Behavior and Function Clinic removes barriers to opioid treatment
Six years after MultiCare Rockwood Clinic established the Healthy Behavior and Function Clinic, its impact on care in the Spokane region has only grown.
As part of the Washington State Health Care Authority’s Hub and Spoke program, the clinic has delivered low-barrier and compassionate medication treatment for opioid use disorder to more than 1,700 patients over the past two years.